Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients willing to provide written informed consent for the study. 2. Diagnosed cases of GERD presenting with evidence of endoscopic findings. 3. Patients with uncomplicated GERD presenting with symptoms of heartburn and regurgitation, and a GERD-Q score more than or equal to 8 confirming clinical diagnosis. Endoscopy will be advised only in patients showing alarming symptoms (such as dysphagia, odynophagia, unintentional weight loss, gastrointestinal bleeding, anaemia or persistent vomiting) or if clinically indicated.
Exclusion criteria
Exclusion criteria: 1. Patients with advanced pathology of GERD or malignancy. 2. Cases suffering from uncontrolled systemic illness or life-threatening conditions. 3. Patients already taking acid suppressing medications or other treatment and not willing to leave it. 4. Pregnant and lactating women. 5. Patients who are immunocompromised. 6. Patients who are unwilling to take part and not giving consent for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of individualized homoeopathic medicines selected using A Clinical Repertory To The Dictionary of Materia Medica by Dr. J. H. Clarke in the management of gastroesophageal reflux disease using a validated GERD symptom score (GERD-Q scale) before and after treatment.Timepoint: Baseline to 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the clinical presentation of gastroesophageal reflux disease in patients reporting to the OPD and to assess the improvement in individual GERD symptoms following individualized homoeopathic treatment.Timepoint: 30 days | — |
Countries
India
Contacts
State National Homoeopathic Medical College And Hospital